Ignite Creation Date:
2025-12-24 @ 11:00 PM
Ignite Modification Date:
2025-12-25 @ 8:29 PM
Study NCT ID:
NCT01803269
Status:
TERMINATED
Last Update Posted:
2020-06-26
First Post:
2013-02-27
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Topotecan Hydrochloride or Cyclodextrin-Based Polymer-Camptothecin CRLX101 in Treating Patients With Recurrent Small Cell Lung Cancer
Sponsor:
University of Chicago
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-01-16
Start Date Type:
ACTUAL
Primary Completion Date:
2016-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-03-30
Completion Date Type:
ACTUAL
First Submit Date:
2013-02-27
First Submit QC Date:
None
Study First Post Date:
2013-03-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-04-01
Results First Submit QC Date:
None
Results First Post Date:
2020-04-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-06-25
Last Update Post Date:
2020-06-26
Last Update Post Date Type:
ACTUAL